1-10 of 10
Michael Linnebacher
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract LB058: A transcriptome-wide gene expression outlier analysis pinpoints therapeutic vulnerabilities in colorectal cancer

Free
Gaia Grasso, Elisa Marriella, Martina Miotto, Kristi Buzo, Nicole M. Reilly, Pietro Andrei, Pietro P. Vitiello, Giovanni Crisafulli, Sabrina Arena, Giuseppe Rospo, Giorgio Corti, Annalisa Lorenzato, Carlotta Cancelliere, Ludovic Barault, Giulia Gionfriddo, Michael Linnebacher, Mariangela Russo, Federica Di Nicolantonio, Alberto Bardelli
Journal: Cancer Research
Cancer Res (2023) 83 (8_Supplement): LB058.
https://doi.org/10.1158/1538-7445.AM2023-LB058
Published: 14 April 2023
View articletitled, Abstract LB058: A transcriptome-wide gene expression outlier analysis pinpoints therapeutic vulnerabilities in colorectal cancer
Journal Articles

Abstract 56: Unlocking primary cell culture for more relevant in vitro models

Free
Benjamin Theek, Anne Franke, David Agorku, Katharina Lamfried, Nojan Jelveh, Michael Linnebacher, Lilian Martinez Carrera, Olaf Hardt
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 56.
https://doi.org/10.1158/1538-7445.AM2023-56
Published: 04 April 2023
View articletitled, Abstract 56: Unlocking primary cell culture for more relevant in vitro models
Journal Articles

Abstract LB-299: A comprehensive platform of patient-derived xenografts and matched cell lines mirrors the genomic landscape of colorectal cancer

Free
Luca Lazzari, Giorgio Corti, Claudio Isella, Monica Montone, Pamela Arcella, Eugenia Zanella, Luca Novara, Fabiane Barbosa, Andrea Cassingena, Carlotta Cancelliere, Enzo Medico, Andrea Sartore-Bianchi, Salvatore Siena, Andrea Bertotti, Livio Trusolino, Federica Di Nicolantonio, Michael Linnebacher, Alberto Bardelli, Sabrina Arena
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): LB-299.
https://doi.org/10.1158/1538-7445.AM2019-LB-299
Published: 01 July 2019
View articletitled, Abstract LB-299: A comprehensive platform of patient-derived xenografts and matched cell lines mirrors the genomic landscape of colorectal cancer
Journal Articles

Abstract 205: Reliance upon ancestral mutations is maintained in colorectal cancers that heterogeneously evolve during targeted therapies

Free
Mariangela Russo, Simona Lamba, Annalisa Lorenzato, Alberto Sogari, Giorgio Corti, Giuseppe Rospo, Monica Montone, Luca Lazzari, Sabrina Arena, Daniele Oddo, Michael Linnebacher, Andrea Sartore-Bianchi, Filippo Pietrantonio, Salvatore Siena, Federica Di Nicolantonio, Alberto Bardelli
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 205.
https://doi.org/10.1158/1538-7445.AM2018-205
Published: 01 July 2018
View articletitled, Abstract 205: Reliance upon ancestral mutations is maintained in colorectal cancers that heterogeneously evolve during targeted therapies
Journal Articles

Molecular Landscape of Acquired Resistance to Targeted Therapy Combinations in BRAF-Mutant Colorectal Cancer

Free
Daniele Oddo, Erin M. Sennott, Ludovic Barault, Emanuele Valtorta, Sabrina Arena, Andrea Cassingena, Genny Filiciotto, Giulia Marzolla, Elena Elez, Robin M.J.M. van Geel, Alice Bartolini, Giovanni Crisafulli, Valentina Boscaro, Jason T. Godfrey, Michela Buscarino, Carlotta Cancelliere, Michael Linnebacher, Giorgio Corti, Mauro Truini, Giulia Siravegna, Julieta Grasselli, Margherita Gallicchio, René Bernards, Jan H.M. Schellens, Josep Tabernero, Jeffrey A. Engelman, Andrea Sartore-Bianchi, Alberto Bardelli, Salvatore Siena, Ryan B. Corcoran, Federica Di Nicolantonio
Journal: Cancer Research
Cancer Res (2016) 76 (15): 4504–4515.
https://doi.org/10.1158/0008-5472.CAN-16-0396
Published: 31 July 2016
View articletitled, Molecular Landscape of Acquired Resistance to Targeted Therapy Combinations in BRAF-Mutant Colorectal Cancer
Open the PDF for Molecular Landscape of Acquired Resistance to Targeted Therapy Combinations in BRAF-Mutant Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract B24: Therapeutic response to bevacicumab, irinotecan, and temozolomide of PDX from human glioma cannot be correlated to common mutations as routinely identified by panel sequencing

Free
Andrea Orthmann, Annika Hoffmann, Reiner Zeisig, Amin EL-Heliebi, Christina Ernst, Johannes Haybäck, Andreas Jödicke, Susanne Kuhn, Michael Linnebacher, Jens Hoffmann, Iduna Fichtner
Journal: Cancer Research
Cancer Res (2015) 75 (23_Supplement): B24.
https://doi.org/10.1158/1538-7445.BRAIN15-B24
Published: 09 December 2015
View articletitled, Abstract B24: Therapeutic response to bevacicumab, irinotecan, and temozolomide of PDX from human glioma cannot be correlated to common mutations as routinely identified by panel sequencing
Journal Articles

Abstract 2043: SATB1 (special AT-rich binding protein 1) as a putative therapeutic target in colorectal cancer

Free
Anja Frömberg, Michael Rabe, Michael Linnebacher, Achim M. Aigner
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 2043.
https://doi.org/10.1158/1538-7445.AM2015-2043
Published: 01 August 2015
View articletitled, Abstract 2043: SATB1 (special AT-rich binding protein 1) as a putative therapeutic target in colorectal cancer
Journal Articles

Systems Biologists Seek Fuller Integration of Systems Biology Approaches in New Cancer Research Programs

Free
Olaf Wolkenhauer, Charles Auffray, Simone Baltrusch, Nils Blüthgen, Helen Byrne, Marta Cascante, Andrea Ciliberto, Trevor Dale, Dirk Drasdo, David Fell, James E. Ferrell, Jr., Daniel Gallahan, Robert Gatenby, Ulrich Günther, Brian D. Harms, Hanspeter Herzel, Christian Junghanss, Manfred Kunz, Ingeborg van Leeuwen, Philippe Lenormand, Francis Levi, Michael Linnebacher, John Lowengrub, Philip K. Maini, Arif Malik, Katja Rateitschak, Owen Sansom, Reinhold Schäfer, Karsten Schürrle, Christine Sers, Santiago Schnell, Darryl Shibata, John Tyson, Julio Vera, Michael White, Boris Zhivotovsky, Robert Jaster
Journal: Cancer Research
Cancer Res (2010) 70 (1): 12–13.
https://doi.org/10.1158/0008-5472.CAN-09-2676
Published: 04 January 2010
View articletitled, Systems Biologists Seek Fuller Integration of Systems Biology Approaches in New Cancer Research Programs
Open the PDF for Systems Biologists Seek Fuller Integration of Systems Biology Approaches in New Cancer Research Programs in another window
Includes: Supplementary data
Journal Articles

P16INK4a is a tumor autoantigen in HR-HPV induced cancers

Free
Nicolas A. Wentzensen, Andreas Kaufmann, Miriam Reuschenbach, Michael Linnebacher, Magnus Von Knebel Doeberitz
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1214.
Published: 01 May 2005
View articletitled, P16INK4a is a tumor autoantigen in HR-HPV induced cancers
Journal Articles

CD40-expressing Carcinoma Cells Induce Down-Regulation of CD40 Ligand (CD154) and Impair T-Cell Functions

Free
Richard Batrla, Michael Linnebacher, Wolfgang Rudy, Susanne Stumm, Diethelm Wallwiener, Brigitte Gückel
Journal: Cancer Research
Cancer Res (2002) 62 (7): 2052–2057.
Published: 01 April 2002
View articletitled, CD40-expressing Carcinoma Cells Induce Down-Regulation of CD40 Ligand (CD154) and Impair T-Cell Functions
Open the PDF for CD40-expressing Carcinoma Cells Induce Down-Regulation of CD40 Ligand (CD154) and Impair T-Cell Functions in another window